...
首页> 外文期刊>Internal medicine journal >Severe hypocalcaemia and hypophosphataemia following intravenous iron and denosumab: a novel drug interaction
【24h】

Severe hypocalcaemia and hypophosphataemia following intravenous iron and denosumab: a novel drug interaction

机译:静脉铁剂和地诺单抗后严重低钙血症和低磷血症:一种新型药物相互作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We present the case of a 59-year-old woman with chronic kidney disease who suffered severe hypocalcaemia and hypophosphataemia after receiving denosumab and intravenous iron. This potentially life-threatening adverse drug interaction has never been reported before. We propose a mechanism to explain it with reference to the physiological derangements caused by both agents on calcium and phosphate homeostasis.
机译:我们提供了一个患有慢性肾脏疾病的59岁妇女的案例,该妇女在接受denosumab和静脉注射铁后遭受严重的低血钙和低血磷。以前从未报道过这种可能威胁生命的不良药物相互作用。我们提出了一种机制来解释它,这是由两种药剂对钙和磷酸盐稳态引起的生理紊乱引起的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号